Sequential Announces Inaugural London Conference on Next-Generation Ingredients, Uniting AI Discovery and Clinical Validation

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Sequential

More Like This

Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients

PR Newswire associated0

Sequential, a leading innovator in microbiome testing, is proud to announce a strategic partnership with Eurosafe, a renowned CRO based in France and operating across Europe

Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for clinical, industrial and research applications (Graphic: Sequentia Biotech)

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications

PR Newswire associated0

Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science

PR Newswire associated0

New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow

PR Newswire associated0

Breakthrough 2024 Speaker Lineup Announced - Industry Experts to Discuss the Evolution of Life Sciences Through Technology, Automation, and Artificial Intelligence

PR Newswire associated0

TraceGains' Annual Together Conference Gathers Food and Beverage Thought Leaders in February 2025 to Tackle Toughest Industry Challenges